Capricor Therapeutics Reports Fourth Quarter and Full Year
CAP-1002 Cell Therapy Programs -Pivotal Phase 3, HOPE-3 Trial Initiation Underway- -Entered Exclusive Partnership with Nippon Shinyaku for...
Source: globenewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Additional Milestone Payments. Real-time updates on events, politics, business and more.